KR101199178B1 - Method for the preparation of chiral beta-fluoroalkylated carbonyl compounds using chiral catalyst - Google Patents

Method for the preparation of chiral beta-fluoroalkylated carbonyl compounds using chiral catalyst Download PDF

Info

Publication number
KR101199178B1
KR101199178B1 KR1020090096840A KR20090096840A KR101199178B1 KR 101199178 B1 KR101199178 B1 KR 101199178B1 KR 1020090096840 A KR1020090096840 A KR 1020090096840A KR 20090096840 A KR20090096840 A KR 20090096840A KR 101199178 B1 KR101199178 B1 KR 101199178B1
Authority
KR
South Korea
Prior art keywords
beta
fluoroalkylated
fluoro
formula
chiral catalyst
Prior art date
Application number
KR1020090096840A
Other languages
Korean (ko)
Other versions
KR20110039826A (en
Inventor
김대영
심성보
강영구
문형욱
Original Assignee
순천향대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 순천향대학교 산학협력단 filed Critical 순천향대학교 산학협력단
Priority to KR1020090096840A priority Critical patent/KR101199178B1/en
Publication of KR20110039826A publication Critical patent/KR20110039826A/en
Application granted granted Critical
Publication of KR101199178B1 publication Critical patent/KR101199178B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00Preparation of sulfones; Preparation of sulfoxides
    • C07C315/04Preparation of sulfones; Preparation of sulfoxides by reactions not involving the formation of sulfone or sulfoxide groups
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/02Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/24Sulfones; Sulfoxides having sulfone or sulfoxide groups and doubly-bound oxygen atoms bound to the same carbon skeleton

Abstract

알파,베타-불포화 케톤 화합물을, 키랄 촉매의 존재하에서, 1-플루오로비스(페닐술포닐)메탄과 반응시켜 베타-플루오로알킬화 카보닐 화합물을 제조하는 방법이 개시된다. 상기 제조방법은, 키랄 촉매를 이용하여 광학 순도가 높은 광학활성물질을 효율적으로 제조할 수 있다.A method of preparing a beta-fluoroalkylated carbonyl compound is disclosed by reacting an alpha, beta-unsaturated ketone compound with 1-fluorobis (phenylsulfonyl) methane in the presence of a chiral catalyst. In the above production method, an optically active material having high optical purity can be efficiently produced using a chiral catalyst.

키랄 촉매, 1-플루오로비스(페닐술포닐)메탄, 알파,베타-불포화 케톤, 광학활성, 베타-플루오로알킬화 카보닐 화합물 Chiral catalyst, 1-fluorobis (phenylsulfonyl) methane, alpha, beta-unsaturated ketones, optically active, beta-fluoroalkylated carbonyl compounds

Description

키랄 촉매를 이용한 키랄 베타-플루오로알킬화 카보닐 화합물의 제조방법{METHOD FOR THE PREPARATION OF CHIRAL BETA-FLUOROALKYLATED CARBONYL COMPOUNDS USING CHIRAL CATALYST}Method for preparing chiral beta-fluoroalkylated carbonyl compound using a chiral catalyst {METHOD FOR THE PREPARATION OF CHIRAL BETA-FLUOROALKYLATED CARBONYL COMPOUNDS USING CHIRAL CATALYST}

본 발명은 키랄 촉매를 이용한 베타-플루오로알킬화 카보닐 화합물의 제조방법에 관한 것이다. The present invention relates to a method for preparing a beta-fluoroalkylated carbonyl compound using a chiral catalyst.

광학이성질체는 밀도, 녹는점, 끓는점 등 대부분의 물리적 성질이 동일하다. 그러나, 편광된 빛을 흡수하는 정도가 다르기 때문에 선형편광된 빛을 조사(照射)했을 때 편광면이 회전하게 되며, 이러한 현상을 광학활성이라고 한다. Optical isomers have almost the same physical properties such as density, melting point, and boiling point. However, since the degree of absorption of polarized light is different, the polarization plane rotates when the linearly polarized light is irradiated. This phenomenon is called optical activity.

물질의 광학활성은 편광계를 사용하여 측정한다. 광학활성은 대칭 중심, 대칭면 또는 회전축 등의 대칭 요소를 갖지 못하는 분자에서 나타난다. 이러한 분자들은, 왼손 또는 오른손과 같이 좌우가 바뀌고 서로 겹쳐지지 않는 거울상체의 관계를 갖는 2 개의 이성질체로 존재할 수 있으며, 이런 성질을 가진 분자를 키랄성 화합물(chiral compound)이라고 한다. The optical activity of the material is measured using a polarimeter. Optical activity occurs in molecules that do not have symmetrical elements such as symmetry centers, symmetry planes, or rotational axes. These molecules can exist as two isomers with enantiomers that change left and right and do not overlap each other, such as the left or right hand, and a molecule having this property is called a chiral compound.

키랄성 화합물은, 탄소에 연결된 4 개의 원자단(原子團)이 모두 다른 비대 칭(키랄중심, chiral center) 탄소를 가진 탄소화합물, 또는 두 자리 리간드를 가진 전이금속착물에서 흔히 볼 수 있다. Chiral compounds are commonly found in carbon compounds with all four asymmetric (chiral center) carbons linked to carbon, or transition metal complexes with bidentate ligands.

본 발명의 일실시예의 목적은 키랄 베타-플루오로알킬화 카보닐 화합물의 제조방법을 제공하는 것이다. It is an object of one embodiment of the present invention to provide a method for preparing a chiral beta-fluoroalkylated carbonyl compound.

본 발명에 따른 제조방법은, 알파,베타-불포화 케톤 화합물을, 키랄 촉매의 존재 하에서, 1-플루오로비스(페닐술포닐)메탄과 반응시켜 베타-플루오로알킬화 카보닐 화합물을 제조하는 것을 특징으로 한다. The production process according to the invention is characterized in that an alpha, beta-unsaturated ketone compound is reacted with 1-fluorobis (phenylsulfonyl) methane in the presence of a chiral catalyst to produce a beta-fluoroalkylated carbonyl compound. It is done.

본 발명에 따른 베타-플루오로알킬화 카보닐 화합물을 제조하는 방법은, 키랄 촉매를 이용하여 광학 순도가 높은 광학활성물질을 효율적으로 제조할 수 있다. The method for producing a beta-fluoroalkylated carbonyl compound according to the present invention can efficiently produce an optically active material having high optical purity using a chiral catalyst.

본 발명의 일실시예에 따른 베타-플루오로알킬화 카보닐 화합물의 제조방법에서, 알파,베타-불포화 케톤 화합물을, 키랄 촉매(chiral catalyst)의 존재하에서, 1-플루오로비스(페닐술포닐)메탄과 반응시켜 베타-플루오로 알킬화된 카보닐 화합물을 제조한다. 상기 제조방법은, 키랄 촉매를 이용하여, 광학 순도가 높은 광학활성물질을 효율적으로 제조하기 위한 것이다.In the method for producing a beta-fluoroalkylated carbonyl compound according to an embodiment of the present invention, the alpha, beta-unsaturated ketone compound is substituted with 1-fluorobis (phenylsulfonyl) in the presence of a chiral catalyst. Reaction with methane produces beta-fluoro alkylated carbonyl compounds. The above production method is for efficiently producing an optically active substance with high optical purity using a chiral catalyst.

본 발명의 일실시예에서, 상기 키랄 촉매는, 키랄 1차 아민 및 3차 아민 그룹이 결합된 키랄 양기능 유기촉매일 수 있다. 키랄 1차 아민과 3차 아민 그룹이 결합 된 키랄 양기능 유기촉매를 이용하는 비대칭 알킬화 반응은, 광학적으로 순수한 키랄 베타-플루오로알킬화 카보닐 화합물을 고수율로 얻을 수 있는 매우 간편하고 유용한 반응이다.In one embodiment of the present invention, the chiral catalyst may be a chiral bifunctional organic catalyst to which chiral primary amines and tertiary amine groups are combined. Asymmetric alkylation using chiral bifunctional organic catalysts in which chiral primary amines and tertiary amine groups are combined is a very simple and useful reaction that can yield optically pure chiral beta-fluoroalkylated carbonyl compounds in high yield.

본 발명의 일실시예에서, 상기 키랄 촉매의 함량은, 반응 물질들의 전체 몰수를 기준으로, 5 내지 20 몰%, 구체적으로는 7 내지 15 몰%, 보다 구체적으로는 9 내지 12 몰%이다. 상기 범위는, 광학 순도가 높은 베타-플루오로알킬화 카보닐 화합물을 효율적으로 제조하기 위한 것이다. 키랄 촉매의 함량이 상기 범위보다 낮은 경우에는, 합성된 베타-플루오로알킬화 카보닐 화합물의 광학 순도가 저하되고, 상기 범위보다 높은 경우에는, 촉매 첨가로 인한 효율성이 떨어질 수 있다.In one embodiment of the present invention, the content of the chiral catalyst is 5 to 20 mol%, specifically 7 to 15 mol%, more specifically 9 to 12 mol%, based on the total moles of the reactants. The above range is for efficiently producing beta-fluoroalkylated carbonyl compounds having high optical purity. When the content of the chiral catalyst is lower than the above range, the optical purity of the synthesized beta-fluoroalkylated carbonyl compound is lowered, and when higher than the above range, the efficiency due to the addition of the catalyst may be lowered.

일실시예에서, 상기 키랄 촉매는, 하기 화학식 1의 구조를 갖는다.In one embodiment, the chiral catalyst, has a structure of formula (1).

Figure 112009062395435-pat00001
Figure 112009062395435-pat00001

Figure 112009062395435-pat00002
Figure 112009062395435-pat00002

상기 화학식 1 또는 화학식 2에서, In Chemical Formula 1 or Chemical Formula 2,

상기 R은 수소, 히드록실 또는 C1~C6의 알콕시이고, 바람직하게는 수소, 히드록실 또는 메톡시이다.R is hydrogen, hydroxyl or alkoxy of C 1 to C 6 , preferably hydrogen, hydroxyl or methoxy.

상기 촉매의 바람직한 구체적인 예로는, 9-아미노-9-디옥시에피퀴닌(9-amino-9-deoxyepiquinine), 9-아미노-9-디옥시에피퀴니딘(9-amino-9-deoxyepiquinidine), 9-아미노-9-디옥시에피신코닌(9-amino-9-deoxyepicinchonine) 또는 9-아미노-9-디옥시에피신코니딘(9-amino-9-deoxyepicinchonidine) 등을 사용할 수 있으며, 더욱 바람직하게는 9-아미노-9-디옥시에피퀴닌(9-amino-9-deoxyepiquinine)을 사용할 수 있다.Preferred specific examples of the catalyst, 9-amino-9-deoxyepiquinine, 9-amino-9-deoxyepiquinidine, 9 -Amino-9-deoxyepicinchonine (9-amino-9-deoxyepicinchonine) or 9-amino-9-deoxyepicinchonidine (9-amino-9-deoxyepicinchonidine) and the like can be used, more preferably 9-amino-9-deoxyepiquinine may be used.

본 발명의 일실시예에서, 상기 알파,베타-불포화 케톤 화합물과 1-플루오로비스(페닐술포닐)메탄과 반응은 산 첨가제 또는 염기 첨가제의 존재하에서 일어날 수 있다.In one embodiment of the present invention, the reaction of the alpha, beta-unsaturated ketone compound with 1-fluorobis (phenylsulfonyl) methane may occur in the presence of an acid additive or a base additive.

상기 산 첨가제는 벤조산(benzoic acid), 포름산(formic acid) 또는 파라니트로벤조산(p-nitro-benzoic acid)일 수 있고, 상기 염기 첨가제는 소디움 아세테이트(sodium acetate), 소디움 벤조에이트(sodium benzoate) 또는 리튬 아세테이 트(lithium acetate)일 수 있다.The acid additive may be benzoic acid, formic acid or paranitrobenzoic acid, and the base additive may be sodium acetate, sodium benzoate or Lithium acetate.

본 발명의 일실시예에서, 상기 알파,베타-불포화 케톤 화합물은 하기 화학식 3의 구조를 갖는다. In one embodiment of the present invention, the alpha, beta-unsaturated ketone compound has the structure of Formula 3 below.

Figure 112009062395435-pat00003
Figure 112009062395435-pat00003

상기 화학식 3에서, In Formula 3,

상기 R1 및 R2는 ⅰ)C1~C40의 알킬기, ⅱ)C1~C40의 알킬렌기, 및 ⅲ)C1~C6의 알킬기, 할로겐 또는 C1~C6의 알콕시에 의해 치환되거나 비치환된, C1~C40의 아릴기로 이루어진 군에서 선택되고, 바람직하게는 ⅰ)C1~C20의 알킬기, ⅱ)C1~C20의 알킬렌기, 및 ⅲ)C1~C6의 알킬기, 할로겐 또는 C1~C6의 알콕시에 의해 치환되거나 비치환된, C1~C20의 아릴기로 이루어진 군에서 선택되며, 더욱 바람직하게는 ⅰ)C1~C10의 알킬기, ⅱ)C1~C10의 알킬렌기, 및 ⅲ)C1~C3의 알킬기, 할로겐 또는 C1~C3의 알콕시에 의해 치환되거나 비치환된, C1~C10의 아릴기로 이루어진 군에서 선택되고, 더욱 더 바람직하게는 ⅰ)C1~C3의 알킬기, ⅱ)C1~C3의 알킬렌기, 및 ⅲ)C1~C3의 알킬기, 할로겐 또는 C1~C3의 알콕시에 의해 치환되거나 비치환된, 페닐 또는 나프틸기로 이루어진 군에서 선택된다. 또한, 상기 R1 및 R2는 상호 동일하거나 상이하고, R1 및 R2 가 서로 연결되어 고리계의 일부를 형성할 수 있다.R 1 and R 2 are selected from the group consisting of: i) C 1 -C 40 alkyl group, ii) C 1 -C 40 alkylene group, and iii) C 1 -C 6 alkyl group, halogen or C 1 -C 6 alkoxy. Substituted or unsubstituted, it is selected from the group consisting of C 1 ~ C 40 aryl group, preferably iii) C 1 ~ C 20 Alkyl group, ii) C 1 ~ C 20 Alkylene group, and iii) C 1 ~ alkyl group of C 6, halogen or C 1 ~ C is substituted by alkoxy of six or unsubstituted, is selected from the group consisting of an aryl group of C 1 ~ C 20, more preferably ⅰ) C alkyl group of 1 ~ C 10, Ii) a C 1 to C 10 alkylene group, and iii) a C 1 to C 3 alkyl group, a C 1 to C 10 aryl group which is unsubstituted or substituted by halogen or C 1 to C 3 alkoxy. And even more preferably iii) C 1 -C 3 alkyl group, ii) C 1 -C 3 alkylene group, and iii) C 1 -C 3 alkyl group, halogen or C 1 -C 3 alkoxy. Phenyl or naph, unsubstituted or substituted by It is selected from the group consisting of a group. In addition, R 1 and R 2 are the same as or different from each other, R 1 and R 2 May be connected to each other to form part of a ring system.

본 발명의 일실시예에서, 상기 1-플루오로비스(페닐술포닐)메탄은 하기 화학식 4의 구조를 갖는 화합물이다. In one embodiment of the present invention, the 1-fluorobis (phenylsulfonyl) methane is a compound having a structure of formula (4).

Figure 112009062395435-pat00004
Figure 112009062395435-pat00004

본 발명의 일실시예에서, 상기 베타-플루오로알킬화 카보닐 화합물은, 화학식 5 또는 화학식 6의 구조를 갖는 화합물일 수 있다.In one embodiment of the present invention, the beta-fluoroalkylated carbonyl compound may be a compound having a structure of Formula 5 or Formula 6.

Figure 112009062395435-pat00005
Figure 112009062395435-pat00005

Figure 112009062395435-pat00006
Figure 112009062395435-pat00006

상기 R1 및 R2는 ⅰ)C1~C40의 알킬기, ⅱ)C1~C40의 알킬렌기, 및 ⅲ)C1~C6의 알킬기, 할로겐 또는 C1~C6의 알콕시에 의해 치환되거나 비치환된, C1~C40의 아릴기로 이루어진 군에서 선택되고, 바람직하게는 ⅰ)C1~C20의 알킬기, ⅱ)C1~C20의 알킬렌기, 및 ⅲ)C1~C6의 알킬기, 할로겐 또는 C1~C6의 알콕시에 의해 치환되거나 비치환된, C1~C20의 아릴기로 이루어진 군에서 선택되며, 더욱 바람직하게는 ⅰ)C1~C10의 알킬기, ⅱ)C1~C10의 알킬렌기, 및 ⅲ)C1~C3의 알킬기, 할로겐 또는 C1~C3의 알콕시에 의해 치환되거나 비치환된, C1~C10의 아릴기로 이루어진 군에서 선택되고, 더욱 더 바람직하게는 ⅰ)C1~C3의 알킬기, ⅱ)C1~C3의 알킬렌기, 및 ⅲ)C1~C3의 알킬기, 할로겐 또는 C1~C3의 알콕시에 의해 치환되거나 비치환된, 페닐 또는 나프틸기로 이루어진 군에서 선택된다. 또한, 상기 R1 및 R2는 상호 동일하거나 상이하고, R1 및 R2 가 서로 연결되어 고리계의 일부를 형성할 수 있다.R 1 and R 2 are selected from the group consisting of: i) C 1 -C 40 alkyl group, ii) C 1 -C 40 alkylene group, and iii) C 1 -C 6 alkyl group, halogen or C 1 -C 6 alkoxy. Substituted or unsubstituted, it is selected from the group consisting of C 1 ~ C 40 aryl group, preferably iii) C 1 ~ C 20 Alkyl group, ii) C 1 ~ C 20 Alkylene group, and iii) C 1 ~ alkyl group of C 6, halogen or C 1 ~ C is substituted by alkoxy of six or unsubstituted, is selected from the group consisting of an aryl group of C 1 ~ C 20, more preferably ⅰ) C alkyl group of 1 ~ C 10, Ii) a C 1 to C 10 alkylene group, and iii) a C 1 to C 3 alkyl group, a C 1 to C 10 aryl group which is unsubstituted or substituted by halogen or C 1 to C 3 alkoxy. And even more preferably iii) C 1 -C 3 alkyl group, ii) C 1 -C 3 alkylene group, and iii) C 1 -C 3 alkyl group, halogen or C 1 -C 3 alkoxy. Phenyl or naph, unsubstituted or substituted by It is selected from the group consisting of a group. In addition, R 1 and R 2 are the same as or different from each other, R 1 and R 2 May be connected to each other to form part of a ring system.

본 발명의 일실시예에 따른 상기 베타-플루오로알킬화 카보닐 화합물은 5-플루오로-4-(p-메틸페닐)-5,5-비스(페닐술포닐)펜탄-2-온, 5-플루오로-4-(p-메톡시페닐)-5,5-비스(페닐술포닐)펜탄-2-온, 5-플루오로-4-(p-플루오로페닐)-5,5-비스(페닐술포닐)펜탄-2-온, 5-플루오로-4-(1-나프틸)-5,5-비스(페닐술포닐)펜탄-2-온, 6-플루오로-5-페닐-6,6-비스(페닐술포닐)헥산-3-온, 6-플루오로-5-메틸-6,6-비스(페닐설폰)헥산-3-온, 3-[플루오로(비스페닐술포닐)메틸]싸이클로헥산온, 3-[플루 오로(비스페닐술포닐)메틸]싸이클로펜탄온 및 5-플루오로-4-페닐-펜탄-2-온으로 이루어진 그룹 중에서 선택될 수 있다.The beta-fluoroalkylated carbonyl compound according to one embodiment of the present invention is 5-fluoro-4- ( p -methylphenyl) -5,5-bis (phenylsulfonyl) pentan-2-one, 5-fluoro Rho-4- ( p -methoxyphenyl) -5,5-bis (phenylsulfonyl) pentan-2-one, 5-fluoro-4- ( p -fluorophenyl) -5,5-bis (phenyl Sulfonyl) pentan-2-one, 5-fluoro-4- (1-naphthyl) -5,5-bis (phenylsulfonyl) pentan-2-one, 6-fluoro-5-phenyl-6, 6-bis (phenylsulfonyl) hexan-3-one, 6-fluoro-5-methyl-6,6-bis (phenylsulfon) hexan-3-one, 3- [fluoro (bisphenylsulfonyl) methyl ] Cyclohexanone, 3- [fluoro (bisphenylsulfonyl) methyl] cyclopentanone, and 5-fluoro-4-phenyl-pentan-2-one.

이하, 본 발명의 일실시예에 따른 베타-플루오로알킬화 카보닐 화합물의 제조방법에 대하여 보다 구체적으로 살펴본다. Hereinafter, a method of preparing a beta-fluoroalkylated carbonyl compound according to an embodiment of the present invention will be described in more detail.

일실시예에서, 알파,베타-불포화 케톤 화합물(화학식 3)을 키랄 촉매의 존재하에서 1-플루오로비스(페닐술포닐)메탄(화학식4)과 반응시켜 베타-플루오로알킬화 카보닐 화합물(화학식 5)을 제조할 수 있다. 구체적인 반응식은, 하기 반응식 1와 같다. In one embodiment, the alpha, beta-unsaturated ketone compound (Formula 3) is reacted with 1-fluorobis (phenylsulfonyl) methane (Formula 4) in the presence of a chiral catalyst to form a beta-fluoroalkylated carbonyl compound (Formula 4) 5) can be prepared. Specific reaction formula is the same as that of Scheme 1 below.

Figure 112009062395435-pat00007
Figure 112009062395435-pat00007

상기 반응식 1에서, R1 내지 R2는 위에서 정의한 바와 같다.In Scheme 1, R 1 to R 2 is as defined above.

화학식 5는 탈술폰화 반응을 통하여 화학식 6의 화합물로 합성할 수 있다.Formula 5 may be synthesized through the desulfonation reaction to the compound of Formula 6.

Figure 112009062395435-pat00008
Figure 112009062395435-pat00008

상기 반응식 2에서, R1 내지 R2는 위에서 정의한 바와 같다.In Scheme 2, R 1 to R 2 is as defined above.

이하, 하기 실시예 등에 의하여 본 발명을 더욱 상세하게 설명하고자 한다. 다만, 하기 실시예 등은 본 발명을 예시하기 위한 것일 뿐 본 발명의 범위가 이들만으로 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to the following examples. However, the following examples and the like are intended to illustrate the present invention, but the scope of the present invention is not limited thereto.

[비교예 1] 5-플루오로-4-페닐-5,5-비스(페닐술포닐)펜탄-2-온:Comparative Example 1 5-Fluoro-4-phenyl-5,5-bis (phenylsulfonyl) pentan-2-one:

Figure 112009062395435-pat00009
Figure 112009062395435-pat00009

플라스크에 상기 키랄 양기능 촉매 10 mol%을 넣고 디클로로메탄(CH2Cl2)과 메탄올(MeOH)을 9:1의 비율로 0.1 mL를 넣은 후 상온에서 교반하였다. 연속해서 4-페닐-3-부텐-2-온 0.0073 g (0.05 mmol), 1-플루오로비스(페닐술포닐)메탄(화학식 4) 0.0314 g(0.1 mmol)을 차례로 가한 후 상온에서 5일 동안 교반하였다. 반응이 완료되면 반응혼합물을 용매를 감압 농축하여 컬럼크로마토그래피(SiO2, EA : Hex = 1 : 5)로 분리 정제하여 5-플루오로-4-페닐-5,5-비스(페닐술포닐)펜탄-2-온을 82% 수율, 9% ee로 얻었다. 여기서 ee는 거울상이성체 과잉률(enantiomeric excess)를 의미한다. 10 mol% of the chiral cationic catalyst was added to the flask, and 0.1 mL of dichloromethane (CH 2 Cl 2 ) and methanol (MeOH) were added at a ratio of 9: 1, followed by stirring at room temperature. Subsequently, 0.0073 g (0.05 mmol) of 4-phenyl-3-buten-2-one and 0.0314 g (0.1 mmol) of 1-fluorobis (phenylsulfonyl) methane (Formula 4) were added sequentially, followed by 5 days at room temperature. Stirred. After the reaction was completed, the reaction mixture was concentrated under reduced pressure to purify the solvent, and then purified by column chromatography (SiO 2 , EA: Hex = 1: 5) to give 5-fluoro-4-phenyl-5,5-bis (phenylsulfonyl). Pentan-2-one was obtained in 82% yield, 9% ee. Where ee means enantiomeric excess.

[비교예 2] 5-플루오로-4-페닐-5,5-비스(페닐술포닐)펜탄-2-온:Comparative Example 2 5-Fluoro-4-phenyl-5,5-bis (phenylsulfonyl) pentan-2-one:

Figure 112009062395435-pat00010
Figure 112009062395435-pat00010

플라스크에 상기 키랄 양기능 촉매 10 mol%을 넣고 디클로로메탄(CH2Cl2)과 메탄올(MeOH)을 9:1의 비율로 0.1 mL를 넣은 후 상온에서 교반하였다. 연속해서 4-페닐-3-부텐-2-온 0.0073 g (0.05 mmol), 1-플루오로비스(페닐술포닐)메탄(화학식 4) 0.0314 g(0.1 mmol)을 차례로 가한 후 상온에서 5일 동안 교반하였다. 반응이 완료되면 반응혼합물을 용매를 감압 농축하여 컬럼크로마토그래피(SiO2, EA : Hex = 1 : 5)로 분리 정제하여 5-플루오로-4-페닐-5,5-비스(페닐술포닐)펜탄-2-온을 79% 수율, 5% ee로 얻었다. 10 mol% of the chiral cationic catalyst was added to the flask, and 0.1 mL of dichloromethane (CH 2 Cl 2 ) and methanol (MeOH) were added at a ratio of 9: 1, followed by stirring at room temperature. Subsequently, 0.0073 g (0.05 mmol) of 4-phenyl-3-buten-2-one and 0.0314 g (0.1 mmol) of 1-fluorobis (phenylsulfonyl) methane (Formula 4) were added sequentially, followed by 5 days at room temperature. Stirred. After the reaction was completed, the reaction mixture was concentrated under reduced pressure to purify the solvent, and then purified by column chromatography (SiO 2 , EA: Hex = 1: 5) to give 5-fluoro-4-phenyl-5,5-bis (phenylsulfonyl). Pentan-2-one was obtained in 79% yield, 5% ee.

[실시예 1] 5-플루오로-4-페닐-5,5-비스(페닐술포닐)펜탄-2-온: Example 1 5-Fluoro-4-phenyl-5,5-bis (phenylsulfonyl) pentan-2-one:

Figure 112009062395435-pat00011
Figure 112009062395435-pat00011

플라스크에 키랄 양기능 촉매(화학식 1, R=OMe) 10 mol%을 넣고 MTBE 0.1 mL를 넣은 후 상온에서 교반하였다. 연속해서 4-페닐-3-부텐-2-온 0.0073 g (0.05 mmol), 1-플루오로비스(페닐술포닐)메탄(화학식 4) 0.0314 g(0.1 mmol)을 차례로 가한 후 상온에서 5일 동안 교반하였다. 반응이 완료되면 반응혼합물을 용매를 감압 농축하여 컬럼크로마토그래피(SiO2, EA : Hex = 1 : 5)로 분리 정제하여 5-플루오로-4-페닐-5,5-비스(페닐술포닐)펜탄-2-온을 87% 수율, 91 % ee로 얻었다. 10 mol% of the chiral cationic catalyst (Formula 1, R = OMe) was added to the flask, and 0.1 mL of MTBE was added thereto, followed by stirring at room temperature. Subsequently, 0.0073 g (0.05 mmol) of 4-phenyl-3-buten-2-one and 0.0314 g (0.1 mmol) of 1-fluorobis (phenylsulfonyl) methane (Formula 4) were added sequentially, followed by 5 days at room temperature. Stirred. After the reaction was completed, the reaction mixture was concentrated under reduced pressure to purify the solvent, and then purified by column chromatography (SiO 2 , EA: Hex = 1: 5) to give 5-fluoro-4-phenyl-5,5-bis (phenylsulfonyl). Pentan-2-one was obtained in 87% yield, 91% ee.

[α]25 D = -130.66 (c = 0.25, CHCl3); 1H NMR (200 MHz, CDCl3) δ = 2.20 (s, 3H), 3.88~3.93 (m, 2H), 4.52~4.60 (m, 1H), 7.00~7.05 (m, 2H), 7.14~7.18 (m, 3H), 7.42~7.50 (m, 2H), 7.57~7.69 (m, 3H), 7.75~7.82 (m, 3H), 7.88~7.93 (m, 2H); 13C NMR (50 MHz, CDCl3) δ = 30.4, 42.1, 43.0 (d, J=19.3), 115.0 (d, J=264.5), 127.9, 128.0, 128.4, 129.2, 130.5, 131.1, 131.3, 133.6 (d, J=4.6), 134.0, 134.9, 135.4, 136.3, 208.0; Chiralpak AS, n-Hexane/i-PrOH = 90:10, flow rate 1.0mL/min, λ=254nm, tR = 21.6 min (minor), tR = 24.1 min (major), 91% ee.[a] 25 D = -130.66 (c = 0.25, CHCl 3 ); 1 H NMR (200 MHz, CDCl 3 ) δ = 2.20 (s, 3H), 3.88 to 3.93 (m, 2H), 4.52 to 4.60 (m, 1H), 7.00 to 7.05 (m, 2H), 7.14 to 7.18 ( m, 3H), 7.42-7.50 (m, 2H), 7.57-7.69 (m, 3H), 7.75-7.82 (m, 3H), 7.88-7.73 (m, 2H); 13 C NMR (50 MHz, CDCl 3 ) δ = 30.4, 42.1, 43.0 (d, J = 19.3), 115.0 (d, J = 264.5), 127.9, 128.0, 128.4, 129.2, 130.5, 131.1, 131.3, 133.6 ( d, J = 4.6), 134.0, 134.9, 135.4, 136.3, 208.0; Chiralpak AS, n-Hexane / i-PrOH = 90:10, flow rate 1.0 mL / min, λ = 254 nm, t R = 21.6 min (minor), t R = 24.1 min (major), 91% ee.

[실시예 2 ~ 8] [Examples 2 to 8]

상기 실시예 1과 동일한 방법으로, 5-플루오로-4-페닐-5,5-비스(페닐술포닐)펜탄-2-온 을 합성하였다. 구체적인 반응조건 및 수율 등은 하기 표 1에 나타내었다. In the same manner as in Example 1, 5-fluoro-4-phenyl-5,5-bis (phenylsulfonyl) pentan-2-one was synthesized. Specific reaction conditions and yields are shown in Table 1 below.

Figure 112009062395435-pat00012
Figure 112009062395435-pat00012

표 1에서 rt는 상온(room temperature)이고, DMSO는 다이메틸설폭사이드(dimethylsulfoxide), DMF는 다이메틸포름아마이드(dimethylformamide), DCM은 디클로로메탄(dichloromethane), MTBE는 메틸 터셔리-부틸 에테르(methyl tert-butyl ether)임.In Table 1, rt is room temperature, DMSO is dimethylsulfoxide, DMF is dimethylformamide, DCM is dichloromethane, and MTBE is methyl tert-butyl ether. tert-butyl ether).

[실시예 9 ~ 12][Examples 9 to 12]

촉매를 달리하여 상기 실시예 1과 동일한 방법으로 5-플루오로-4-페닐-5,5-비스(페닐술포닐)펜탄-2-온 을 합성하였다. Different catalysts were used to synthesize 5-fluoro-4-phenyl-5,5-bis (phenylsulfonyl) pentan-2-one in the same manner as in Example 1.

Figure 112009062395435-pat00013
Figure 112009062395435-pat00013

표 2에서 rt는 상온(room temperature)이고, DCM은 디클로로메탄(dichloromethane)이며, OH는 히드록실, H는 수소, OMe는 메톡시임.In Table 2, rt is room temperature, DCM is dichloromethane, OH is hydroxyl, H is hydrogen, and OMe is methoxy.

[실시예 13 ~ 18][Examples 13 to 18]

첨가제로 다른 산이나 염기를 넣고 상기 실시예 1과 동일한 방법으로 5-플루오로-4-페닐-5,5-비스(페닐술포닐)펜탄-2-온 을 합성하였다. 구체적인 반응조건 및 수율 등은 하기 표 3에 나타내었다. Another acid or base was added as an additive, and 5-fluoro-4-phenyl-5,5-bis (phenylsulfonyl) pentan-2-one was synthesized in the same manner as in Example 1. Specific reaction conditions and yields are shown in Table 3 below.

Figure 112009062395435-pat00014
Figure 112009062395435-pat00014

[실시예 19] 5-플루오로-4-(p-메틸페닐)-5,5-비스(페닐술포닐)펜탄-2-온: Example 19 5-Fluoro-4- ( p -methylphenyl) -5,5-bis (phenylsulfonyl) pentan-2-one:

Figure 112009062395435-pat00015
Figure 112009062395435-pat00015

상기 실시예 1과 동일한 방법으로, 5-플루오로-4-(p-메틸페닐)-5,5-비스(페닐술포닐)펜탄-2-온을 90% 수율, 90% ee 로 얻었다.In the same manner as in Example 1, 5-fluoro-4- ( p -methylphenyl) -5,5-bis (phenylsulfonyl) pentan-2-one was obtained in 90% yield and 90% ee.

[α]25 D = -130.1 (c = 0.22, CHCl3); 1H NMR (200 MHz, CDCl3) δ = 2.19 (s, 3H), 2.25 (s, 3H), 3.86~3.89 (m, 2H), 4.47~4.52 (m, 1H), 6.88~6.99 (m, 4H), 7.41~7.49 (m. 2H), 7.55~7.69 (m, 3H), 7.73~7.90 (m, 5H); 13C NMR (50 MHz) δ = 20.9, 30.3, 42.2, 42.7 (d, J=19.0 Hz), 128.4, 128.7,129.1,130.2, 131.0, 131.2, 134.8, 135.3, 192.0 Chiralpak AD-H, n-Hexane/ i-PrOH = 90:10, flow rate 1.0mL/min, λ= 254nm, tR = 17.7 min (major), tR = 21.6 min (minor), 90% ee.[α] 25 D = -130.1 (c = 0.22, CHC1 3 ); 1 H NMR (200 MHz, CDCl 3 ) δ = 2.19 (s, 3H), 2.25 (s, 3H), 3.86 to 3.89 (m, 2H), 4.47 to 4.52 (m, 1H), 6.88 to 6.99 (m, 4H), 7.41-7.49 (m. 2H), 7.55-7.69 (m, 3H), 7.73-7.90 (m, 5H); 13 C NMR (50 MHz) δ = 20.9, 30.3, 42.2, 42.7 (d, J = 19.0 Hz), 128.4, 128.7,129.1,130.2, 131.0, 131.2, 134.8, 135.3, 192.0 Chiralpak AD-H, n-Hexane / i-PrOH = 90:10, flow rate 1.0 mL / min, λ = 254 nm, t R = 17.7 min (major), t R = 21.6 min (minor), 90% ee.

[실시예 20] 5-플루오로-4-(p-메톡시페닐)-5,5-비스(페닐술포닐)펜탄-2-온: Example 20 5-Fluoro-4- ( p -methoxyphenyl) -5,5-bis (phenylsulfonyl) pentan-2-one:

Figure 112009062395435-pat00016
Figure 112009062395435-pat00016

상기 실시예 1과 동일한 방법으로, 5-플루오로-4-(p-메톡시페닐)-5,5-비스(페닐술포닐)펜탄-2-온을 92% 수율, 93% ee 로 얻었다. In the same manner as in Example 1, 5-fluoro-4- ( p -methoxyphenyl) -5,5-bis (phenylsulfonyl) pentan-2-one was obtained in 92% yield and 93% ee.

[α]25 D = -150.2 (c = 0.22, CHCl3); 1H NMR (200 MHz, CDCl3) δ = 2.19 (s, 3H), 3.73 (s, 3H), 3.85 (d, J=6.4 Hz), 4.45~4.53 (m, 1H), 6.66~6.70 (m, 2H), 6.93~6.97 (m, 2H), 7.42~7.49 (m, 2H), 7.56~7.68 (m, 3H), 7.73~7.82 (m, 3H), 7.87~7.90 (m, 2H); 13C NMR (50 MHz, CDCl3) δ = 30.2, 42.3 (d, J=19.2 Hz), 54.9, 113.2, 114.9 (d, J=264.3 Hz), 125.2, 125.3, 128.3, 130.0, 130.9, 131.1, 131.4, 134..0, 134.7, 135.2, 136.2, 159.0, 203.9; Chiralpak AD-H, n-Hexane/i-PrOH = 90:10, flow rate 1.0mL/min, λ = 254nm, tR = 29.1 (major), min, tR = 32.7 min (minor), 93% ee.[a] 25 D = -150.2 (c = 0.22, CHC1 3 ); 1 H NMR (200 MHz, CDCl 3 ) δ = 2.19 (s, 3H), 3.73 (s, 3H), 3.85 (d, J = 6.4 Hz), 4.45 to 4.53 (m, 1H), 6.66 to 6.70 (m , 2H), 6.93-6.97 (m, 2H), 7.42-7.49 (m, 2H), 7.56-77.6 (m, 3H), 7.73-7.82 (m, 3H), 7.87-7.90 (m, 2H); 13 C NMR (50 MHz, CDCl 3 ) δ = 30.2, 42.3 (d, J = 19.2 Hz), 54.9, 113.2, 114.9 (d, J = 264.3 Hz), 125.2, 125.3, 128.3, 130.0, 130.9, 131.1, 131.4, 134..0, 134.7, 135.2, 136.2, 159.0, 203.9; Chiralpak AD-H, n-Hexane / i-PrOH = 90:10, flow rate 1.0 mL / min, λ = 254 nm, t R = 29.1 (major), min, t R = 32.7 min (minor), 93% ee .

[실시예 21] 5-플루오로-4-(p-플루오로페닐)-5,5-비스(페닐술포닐)펜탄-2-온:Example 21 5-Fluoro-4- ( p -fluorophenyl) -5,5-bis (phenylsulfonyl) pentan-2-one:

Figure 112009062395435-pat00017
Figure 112009062395435-pat00017

상기 실시예 1과 동일한 방법으로, 5-플루오로-4-(p-플루오로페닐)-5,5-비스(페닐술포닐)펜탄-2-온을 90% 수율, 86% ee 로 얻었다.In the same manner as in Example 1, 5-fluoro-4- ( p -fluorophenyl) -5,5-bis (phenylsulfonyl) pentan-2-one was obtained in 90% yield and 86% ee.

[α]25 D = -104.6 (c = 0.21, CHCl3); 1H NMR (200 MHz, CDCl3) δ = 2.20 (s, 3H). 3.86-3.89 (m, 2H), 4.45-5.59 (m, 1H), 6.80-6.89 (m, 2H), 6.97-7.04 (m, 2H), 7.44-7.51 (m, 2H), 7.44-7.51 (m, 2H), 7.57-7.71 (m, 3H), 7.75-7.90 (m, 5H); 13C NMR (50 MHz, CDCl3) δ = 30.3, 42.2 (d, J=6.2 Hz), 42.4 (d, J=11.0 Hz), 114.7 (d, J=265.3 Hz), 114.9 (d, J=21.8 Hz), 128.5, 129.2, 129.3 (t, J=3.9 Hz), 131.0, 131.2, 132.1 (d, J=8.4 Hz), 133.9, 135.0, 135.5, 136.1, 162.3 (d, J=264.2 Hz), 203.8; Chiralcel OD-H, n-Hexane/i-PrOH = 90:10, flow rate 1.0mL/min, λ = 254nm, tR = 13.0 min (minor), tR = 14.4 min (major), 81% ee.[a] 25 D = -104.6 (c = 0.21, CHC1 3 ); 1 H NMR (200 MHz, CDCl 3 ) δ = 2.20 (s, 3H). 3.86-3.89 (m, 2H), 4.45-5.59 (m, 1H), 6.80-6.89 (m, 2H), 6.97-7.04 (m, 2H), 7.44-7.51 (m, 2H), 7.44-7.51 (m , 2H), 7.57-7.71 (m, 3H), 7.75-7.90 (m, 5H); 13 C NMR (50 MHz, CDCl 3 ) δ = 30.3, 42.2 (d, J = 6.2 Hz), 42.4 (d, J = 11.0 Hz), 114.7 (d, J = 265.3 Hz), 114.9 (d, J = 21.8 Hz), 128.5, 129.2, 129.3 (t, J = 3.9 Hz), 131.0, 131.2, 132.1 (d, J = 8.4 Hz), 133.9, 135.0, 135.5, 136.1, 162.3 (d, J = 264.2 Hz), 203.8; Chiralcel OD-H, n-Hexane / i-PrOH = 90:10, flow rate 1.0 mL / min, λ = 254 nm, t R = 13.0 min (minor), t R = 14.4 min (major), 81% ee.

[실시예 22] 5-플루오로-4-(1-나프틸)-5,5-비스(페닐술포닐)펜탄-2-온:Example 22 5-Fluoro-4- (1-naphthyl) -5,5-bis (phenylsulfonyl) pentan-2-one:

Figure 112009062395435-pat00018
Figure 112009062395435-pat00018

상기 실시예 1과 동일한 방법으로, 5-플루오로-4-(1-나프틸)-5,5-비스(페닐술포닐)펜탄-2-온을 75% 수율, 86% ee 로 얻었다.In the same manner as in Example 1, 5-fluoro-4- (1-naphthyl) -5,5-bis (phenylsulfonyl) pentan-2-one was obtained in 75% yield and 86% ee.

[α]25 D = -210.2 (c = 0.44, CHCl3); 1H NMR (200 MHz, CDCl3)δ = 2.18 (s, 3H), 4.06-4.17 (m, 2H), 5.40-5.47 (m, 1H), 6.71-6.75 (m, 1H), 6.93~7.01 (m, 1H), 7.30~7.46 (m, 4H), 7.55-7.77 (m, 8H), 7.95-7.98 (m, 3H) 13C NMR (50 MHz, CDCl3) δ = 30.3, 37.2 (d, J=19.6 Hz), 43.2, 116.6 (d, J=260 Hz), 122.8, 124.9, 125.1, 126.1, 128.3, 128.4, 128.6, 129.1, 129.5, 129.6, 130.2, 131.0, 131.7, 133.5, 134.0, 134.7, 134.8, 135.5, 135.6, 136.5, 204.0; Chiralpak AD-H, n-Hexane/EtOH = 90:10, flow rate 1.0mL/min, λ = 254nm, tR= 22.2 min (major), tR = 34.1 min (minor), 86% ee.[a] 25 D = -210.2 (c = 0.44, CHC1 3 ); 1 H NMR (200 MHz, CDCl 3 ) δ = 2.18 (s, 3H), 4.06-4.17 (m, 2H), 5.40-5.47 (m, 1H), 6.71-6.75 (m, 1H), 6.93-7.01 ( m, 1H), 7.30-7.46 (m, 4H), 7.55-7.77 (m, 8H), 7.95-7.98 (m, 3H) 13 C NMR (50 MHz, CDCl 3 ) δ = 30.3, 37.2 (d, J = 19.6 Hz), 43.2, 116.6 (d, J = 260 Hz), 122.8, 124.9, 125.1, 126.1, 128.3, 128.4, 128.6, 129.1, 129.5, 129.6, 130.2, 131.0, 131.7, 133.5, 134.0, 134.7, 134.8 , 135.5, 135.6, 136.5, 204.0; Chiralpak AD-H, n-Hexane / EtOH = 90:10, flow rate 1.0 mL / min, λ = 254 nm, t R = 22.2 min (major), t R = 34.1 min (minor), 86% ee.

[실시예 23] 6-플루오로-5-페닐-6,6-비스(페닐술포닐)헥산-3-온:Example 23 6-Fluoro-5-phenyl-6,6-bis (phenylsulfonyl) hexan-3-one:

Figure 112009062395435-pat00019
Figure 112009062395435-pat00019

상기 실시예 1과 동일한 방법으로, 6-플루오로-5-페닐-6,6-비스(페닐술포닐)헥산-3-온을 82% 수율, 75% ee 로 얻었다.In the same manner as in Example 1, 6-fluoro-5-phenyl-6,6-bis (phenylsulfonyl) hexan-3-one was obtained in 82% yield and 75% ee.

[α]25 D = -153.16 (c = 0.24, CHCl3); 1H NMR (200 MHz, CDCl3) δ = 1.00 (t, 3H), 2.26~2.66 (m, 2H), 3.85~3.89 (m, 2H), 4.54-4.62 (m, 1H), 6.99~7.01 (m, 2H), 7.12~7.14 (m, 3H), 7.41~7.45 (m, 2H), 7.56~7.68 (m, 3H), 7.73-7.82 (m, 3H), 7.92-8.10 (m, 2H); 13C NMR (50 MHz, CDCl3) δ = 7.76, 32.9 (d, J=18.2), 36.4, 43.1 (d, J=4.9), 116.3 (d, J=264.7), 128.8, 129.0, 131.0, 135.0, 135.1, 135.2, 136.0, 208.0; Chiralpak AD-H, n-Hexane/EtOH = 90:10, flow rate 1.0mL/min, λ = 254nm, tR = 15.1 min (major), tminor = 17.9 min (minor), 75% ee.[a] 25 D = -153.16 (c = 0.24, CHC1 3 ); 1 H NMR (200 MHz, CDCl 3 ) δ = 1.00 (t, 3H), 2.26 to 2.66 (m, 2H), 3.85 to 3.89 (m, 2H), 4.54-4.62 (m, 1H), 6.99 to 7.01 ( m, 2H), 7.12-7.14 (m, 3H), 7.41-7.45 (m, 2H), 7.56-77.6 (m, 3H), 7.73-7.82 (m, 3H), 7.92-8.10 (m, 2H); 13 C NMR (50 MHz, CDCl 3 ) δ = 7.76, 32.9 (d, J = 18.2), 36.4, 43.1 (d, J = 4.9), 116.3 (d, J = 264.7), 128.8, 129.0, 131.0, 135.0 , 135.1, 135.2, 136.0, 208.0; Chiralpak AD-H, n-Hexane / EtOH = 90:10, flow rate 1.0 mL / min, λ = 254 nm, t R = 15.1 min (major), t minor = 17.9 min (minor), 75% ee.

[실시예 24] 6-플루오로-5-메틸-6,6-비스(페닐설폰)헥산-3-온:Example 24 6-Fluoro-5-methyl-6,6-bis (phenylsulfon) hexan-3-one:

Figure 112009062395435-pat00020
Figure 112009062395435-pat00020

상기 실시예 1과 동일한 방법으로, 6-플루오로-5-메틸-6,6-비스(페닐술포닐)헥산-3-온을 85% 수율, 80% ee 로 얻었다.In the same manner as in Example 1, 6-fluoro-5-methyl-6,6-bis (phenylsulfonyl) hexan-3-one was obtained in 85% yield and 80% ee.

[α]20 D = -88.5 (c = 0.04, CHCl3); 1H NMR (200 MHz, CDCl3) δ = 1.04-1.11 (m, 3H), 1.27-1.31 (m, 3H), 2.35-2.60 (m, 2H), 2.90-3.04 (m, 1H), 3.15-3.26 (m, 2H), 3.43-3.53 (m, 1H), 7.50-7.60 (m, 4H), 7.65-7.77 (m, 2H), 7.93-7.96 (m, 2H) 13C NMR (50 MHz) δ = 7.8, 14.7, 32.9 (d, J=18.0 Hz), 36.4, 43.0, 113.6 (d, J=350 Hz).1128., 129.0, 129.5, 130.2, 131.0, 135.1, 135.7,136.0, 205.4; Chiralpak AD-H, n-Hexane/i-PrOH = 90:10, flow rate 1.0mL/min, λ = 254nm, tR = 14.5 min (major), tR = 18.8 min (minor), 80% ee.[α] 20 D = -88.5 (c = 0.04, CHC1 3 ); 1 H NMR (200 MHz, CDCl 3 ) δ = 1.04-1.11 (m, 3H), 1.27-1.31 (m, 3H), 2.35-2.60 (m, 2H), 2.90-3.04 (m, 1H), 3.15- 3.26 (m, 2H), 3.43-3.53 (m, 1H), 7.50-7.60 (m, 4H), 7.65-7.77 (m, 2H), 7.93-7.96 (m, 2H) 13 C NMR (50 MHz) δ = 7.8, 14.7, 32.9 (d, J = 18.0 Hz), 36.4, 43.0, 113.6 (d, J = 350 Hz). 1128., 129.0, 129.5, 130.2, 131.0, 135.1, 135.7, 136.0, 205.4; Chiralpak AD-H, n-Hexane / i-PrOH = 90:10, flow rate 1.0 mL / min, λ = 254 nm, t R = 14.5 min (major), t R = 18.8 min (minor), 80% ee.

[실시예 25] 3-[플루오로(비스페닐술포닐)메틸]싸이클로헥산온:Example 25 3- [fluoro (bisphenylsulfonyl) methyl] cyclohexanone:

Figure 112009062395435-pat00021
Figure 112009062395435-pat00021

상기 실시예 1과 동일한 방법으로, 3-[플루오로(비스페닐술포닐)메틸]싸이클로헥산온을 93% 수율, 89% ee 로 얻었다. In the same manner as in Example 1, 3- [fluoro (bisphenylsulfonyl) methyl] cyclohexanone was obtained in 93% yield and 89% ee.

[α]20 D = -98.3 (c = 0.03, CHCl3); 1H NMR (200 MHz, CDCl3) δ = 1.41-1.57 (m, 1H), 2.16-2.26 (m, 1H), 2.33-2.48 (m, 3H), 2.53-2.75 (m, 3H), 2.99-3.12 (m, 1H) 13C NMR (50 MHz, CDCl3) δ = 20.5, 25.2, 41.2, 41.5 (d, J = 6.7 Hz), 111.0 (d, J = 145 Hz), 128.9, 129.1, 130.7, 130.9, 135.2, 135.3, 209.3 Chiralcel OD-H, n-Hexane/i-PrOH = 90:10, flow rate 1.0mL/min, λ = 254nm, tR= 27.9 min (major), tR = 31.0 min (minor), 89% ee.[a] 20 D = -98.3 (c = 0.03, CHCl 3 ); 1 H NMR (200 MHz, CDCl 3 ) δ = 1.41-1.57 (m, 1H), 2.16-2.26 (m, 1H), 2.33-2.48 (m, 3H), 2.53-2.75 (m, 3H), 2.99- 3.12 (m, 1H) 13 C NMR (50 MHz, CDCl 3 ) δ = 20.5, 25.2, 41.2, 41.5 (d, J = 6.7 Hz), 111.0 (d, J = 145 Hz), 128.9, 129.1, 130.7, 130.9, 135.2, 135.3, 209.3 Chiralcel OD-H, n-Hexane / i-PrOH = 90:10, flow rate 1.0mL / min, λ = 254nm, t R = 27.9 min (major), t R = 31.0 min ( minor), 89% ee.

[실시예 26] 3-[플루오로(비스페닐술포닐)메틸]싸이클로펜탄온:Example 26 3- [fluoro (bisphenylsulfonyl) methyl] cyclopentanone:

Figure 112009062395435-pat00022
Figure 112009062395435-pat00022

상기 실시예 1과 동일한 방법으로, 3-[플루오로(비스페닐술포닐)메틸]싸이클로펜탄온을 87% 수율, 86% ee 로 얻었다. In the same manner as in Example 1, 3- [fluoro (bisphenylsulfonyl) methyl] cyclopentanone was obtained in 87% yield and 86% ee.

[α]20 D = -27.00 (c = 0.08, CHCl3); 1H NMR (200 MHz, CDCl3) δ = 2.03~2.26 (m 2H), 2.45~2.72 (m, 3H), 2.88~3.03 (m, 1H), 3.12~3.27 (m, 1H), 7.73~7.45 (m, 4H), 7.66~7.82 (m, 6H); 13C NMR (50 MHz, CDCl3) δ = 23.8 (d, J=4.6), 37.5, 39.4 (d, J=3.1), 39.7 (d, J=10.9), 116.4 (d, J=265.7), 129.0, 129.1, 130.7, 135.30, 215.2; Chiralcel OD-H, n-Hexane/i-PrOH = 90:10, flow rate 1.0mL/min, λ = 254nm, tR = 10.4 min (major), tR = 12.5 min (minor), 86% ee.[a] 20 D = -27.00 (c = 0.08, CHC1 3 ); 1 H NMR (200 MHz, CDCl 3 ) δ = 2.03-2.26 (m 2H), 2.45-2.72 (m, 3H), 2.88-3.03 (m, 1H), 3.12-3.27 (m, 1H), 7.73-7.45 (m, 4H), 7.66-7.82 (m, 6H); 13 C NMR (50 MHz, CDCl 3 ) δ = 23.8 (d, J = 4.6), 37.5, 39.4 (d, J = 3.1), 39.7 (d, J = 10.9), 116.4 (d, J = 265.7), 129.0, 129.1, 130.7, 135.30, 215.2; Chiralcel OD-H, n-Hexane / i-PrOH = 90:10, flow rate 1.0 mL / min, λ = 254 nm, t R = 10.4 min (major), t R = 12.5 min (minor), 86% ee.

[실시예 27] 5-플루오로-4-페닐-펜탄-2-온 : Example 27 5-Fluoro-4-phenyl-pentan-2-one:

Figure 112009062395435-pat00023
Figure 112009062395435-pat00023

일실시예에서, 5-플루오로-4-페닐-5,5-비스(페닐술포닐)펜탄-2-온을 탈 술폰화 반응시켜 5-플루오로-4-페닐-펜탄-2-온을 제조할 수 있다. 구체적인 반응식은, 하기 반응식 3와 같다.In one embodiment, 5-fluoro-4-phenyl-5,5-bis (phenylsulfonyl) pentan-2-one is desulfonated to yield 5-fluoro-4-phenyl-pentan-2-one. It can manufacture. The specific reaction formula is the same as the following scheme 3.

Figure 112009062395435-pat00024
Figure 112009062395435-pat00024

91%의 거울상 이성질체 과잉률을 갖는 생성물을 NaBH4를 사용하여 환원시킨 후에 활성화된 Mg 와 I2를 사용하여 99%의 수율로 술폰 기질을 제거하였다. 그리고 카보닐을 원래대로 복원하기 위해 PCC를 사용하여 산화시켜 베타 플루오로알킬화 케톤 생성물을 90%의 수율로 얻었다. 세 단계의 반응을 진행하였으며 거울상 이성질체 과잉률은 변함없이 91 %로 5-플루오로-4-페닐-펜탄-2-온을 얻었다. The product having an enantiomeric excess of 91% was reduced using NaBH 4 and then the sulfone substrate was removed in 99% yield using Mg and I 2 activated. The carbonyls were then oxidized using PCC to restore the beta fluoroalkylated ketone product in 90% yield. The reaction proceeded in three stages, yielding 5-fluoro-4-phenyl-pentan-2-one at 91% with constant enantiomeric excess.

[α]20 D = -25.60 (c = 0.04, CHCl3); 1H NMR (200 MHz, CDCl3) δ = 2.12 (s 3H), 2.76~3.07 (m, 2H), 3.45~3.68 (m, 1H), 4.33~4.50 (m, 1H), 4.56~4.71 (m, 1H), 7.22~7.36 (m, 5H); 13C NMR (50 MHz, CDCl3) δ = 30.4, 41.3 (d, J=18.7), 45.1 (d, J=4.1), 86.1 (d, J=3.4), 127.2, 127.8, 128.7, 130.8, 206.5; Astec ChiraldexTM G-TA (50oC), tR = 59.5 min (major), tR = 66.1 min (minor), 91% ee.[a] 20 D = -25.60 (c = 0.04, CHC1 3 ); 1 H NMR (200 MHz, CDCl 3 ) δ = 2.12 (s 3H), 2.76 to 3.07 (m, 2H), 3.45 to 3.68 (m, 1H), 4.33 to 4.50 (m, 1H), 4.56 to 4.71 (m , 1H), 7.22-7.36 (m, 5H); 13 C NMR (50 MHz, CDCl 3 ) δ = 30.4, 41.3 (d, J = 18.7), 45.1 (d, J = 4.1), 86.1 (d, J = 3.4), 127.2, 127.8, 128.7, 130.8, 206.5 ; Astec Chiraldex G-TA (50 o C), t R = 59.5 min (major), t R = 66.1 min (minor), 91% ee.

Claims (11)

알파,베타-불포화 케톤 화합물을 키랄 촉매의 존재 하에서, 1-플루오로비스(페닐술포닐)메탄과 반응시키는 것을 포함하는 키랄 촉매를 이용한 베타-플루오로알킬화 카보닐 화합물의 제조방법이고,A method for preparing a beta-fluoroalkylated carbonyl compound using a chiral catalyst comprising reacting an alpha, beta-unsaturated ketone compound with 1-fluorobis (phenylsulfonyl) methane in the presence of a chiral catalyst, 상기 키랄 촉매는 키랄 1차 아민 및 3차 아민 그룹이 결합된 키랄 양기능 유기촉매로, 하기 화학식 1 또는 화학식 2의 구조를 가지고,The chiral catalyst is a chiral bifunctional organic catalyst to which a chiral primary amine and a tertiary amine group are bonded, and have a structure of the following Chemical Formula 1 or Formula 2, <화학식 1>&Lt; Formula 1 >
Figure 112012041152448-pat00030
Figure 112012041152448-pat00030
<화학식 2><Formula 2>
Figure 112012041152448-pat00031
Figure 112012041152448-pat00031
(상기 화학식 1 또는 화학식 2에서, (In Formula 1 or Formula 2, 상기 R은 수소, 히드록실 또는 C1~C6의 알콕시임.)R is hydrogen, hydroxyl or alkoxy of C 1 to C 6 . 상기 알파,베타-불포화 케톤 화합물은 하기 화학식 3의 구조를 갖는 것이며,The alpha, beta-unsaturated ketone compound has a structure of Formula 3, 상기 베타-플루오로알킬화 카보닐 화합물은 하기 화학식 5의 구조를 갖는 것을 특징으로 하는 키랄 촉매를 이용한 베타-플루오로알킬화 카보닐 화합물의 제조방법:Method for producing a beta-fluoroalkylated carbonyl compound using a chiral catalyst, characterized in that the beta-fluoroalkylated carbonyl compound has a structure of Formula 5 <화학식 3><Formula 3>
Figure 112012041152448-pat00027
Figure 112012041152448-pat00027
<화학식 5>&Lt; Formula 5 >
Figure 112012041152448-pat00028
Figure 112012041152448-pat00028
(상기 화학식 3 또는 화학식 5에서, (In Formula 3 or Formula 5, 상기 R1 및 R2는 ⅰ)C1~C40의 알킬기, ⅱ)C2~C40의 알킬렌기, 및 ⅲ)C1~C6의 알킬기, 할로겐 또는 C1~C6의 알콕시에 의해 치환되거나 비치환된, C6~C40의 아릴기로 이루어진 군에서 선택되고, 상호 동일하거나 상이하며, R1 및 R2 가 서로 연결되어 고리계의 일부를 형성할 수 있음.)R 1 and R 2 are selected from (i) C 1 -C 40 alkyl group, ii) C 2 -C 40 alkylene group, and (iii) C 1 -C 6 alkyl group, halogen or C 1 -C 6 alkoxy. Selected from the group consisting of a substituted or unsubstituted C 6 -C 40 aryl group, the same or different from each other, and R 1 and R 2 may be connected to each other to form part of a ring system.)
삭제delete 제 1 항에 있어서,The method of claim 1, 상기 키랄 촉매의 함량은 반응 물질들의 전체 몰수를 기준으로, 5 내지 20 몰%인 것을 특징으로 하는 키랄 촉매를 이용한 베타-플루오로알킬화 카보닐 화합물의 제조방법.The content of the chiral catalyst is 5 to 20 mol% based on the total number of moles of the reaction materials, the method for producing a beta-fluoroalkylated carbonyl compound using a chiral catalyst. 삭제delete 제 1항 또는 제 3항에 있어서,The method according to claim 1 or 3, 상기 키랄 촉매는 9-아미노-9-디옥시에피퀴닌(9-amino-9-deoxyepiquinine), 9-아미노-9-디옥시에피퀴니딘(9-amino-9-deoxyepiquinidine), 9-아미노-9-디옥시에피신코닌(9-amino-9-deoxyepicinchonine) 또는 9-아미노-9-디옥시에피신코니딘(9-amino-9-deoxyepicinchonidine)인 것을 특징으로 하는 키랄 촉매를 이용한 베타-플루오로알킬화 카보닐 화합물의 제조방법.The chiral catalyst is 9-amino-9-deoxyepiquinine, 9-amino-9-deoxyepiquinidine, 9-amino-9 Beta-fluoro using a chiral catalyst characterized in that it is 9-amino-9-deoxyepicinchonine or 9-amino-9-deoxyepicinchonidine Process for the preparation of alkylated carbonyl compounds. 제 1 항에 있어서,The method of claim 1, 상기 반응은 산 첨가제 또는 염기 첨가제의 존재 하에서 일어나는 것을 특징으로 하는 키랄 촉매를 이용한 베타-플루오로알킬화 카보닐 화합물의 제조방법.The reaction is a method for producing a beta-fluoroalkylated carbonyl compound using a chiral catalyst, characterized in that in the presence of an acid additive or a base additive. 제 6 항에 있어서,The method of claim 6, 상기 산은 벤조산(benzoic acid), 포름산(formic acid) 또는 파라니트로벤조산(p-nitro-benzoic acid)이고, 상기 염기는 소디움 아세테이트(sodium acetate), 소디움 벤조에이트(sodium benzoate) 또는 리튬 아세테이트(lithium acetate)인 것을 특징으로 하는 키랄 촉매를 이용한 베타-플루오로알킬화 카보닐 화합물의 제조방법.The acid is benzoic acid, formic acid or paranitrobenzoic acid, and the base is sodium acetate, sodium benzoate or lithium acetate. A method for producing a beta-fluoroalkylated carbonyl compound using a chiral catalyst, characterized in that). 삭제delete 삭제delete 제 1항에 의해 제조된 베타-플루오로알킬화 카보닐 화합물을 탈술폰화 반응시켜 하기 화학식 6의 구조를 갖는 베타-플루오로알킬화 카보닐 화합물을 제조하는 것을 포함하는 키랄 촉매를 이용한 베타-플루오로알킬화 카보닐 화합물의 제조방법:Beta-fluoroalkylation using a chiral catalyst comprising desulfonating a beta-fluoroalkylated carbonyl compound prepared by claim 1 to produce a beta-fluoroalkylated carbonyl compound having the structure Process for preparing carbonyl compound: <화학식 6>(6)
Figure 112012041152448-pat00029
Figure 112012041152448-pat00029
(상기 화학식 6에서, (In Chemical Formula 6, 상기 R1 및 R2는 ⅰ)C1~C40의 알킬기, ⅱ)C2~C40의 알킬렌기, 및 ⅲ)C1~C6의 알킬기, 할로겐 또는 C1~C6의 알콕시에 의해 치환되거나 비치환된, C6~C40의 아릴기로 이루어진 군에서 선택되고, 상호 동일하거나 상이하며, R1 및 R2 가 서로 연결되어 고리계의 일부를 형성할 수 있음.)R 1 and R 2 are selected from (i) C 1 -C 40 alkyl group, ii) C 2 -C 40 alkylene group, and (iii) C 1 -C 6 alkyl group, halogen or C 1 -C 6 alkoxy. Selected from the group consisting of a substituted or unsubstituted C 6 -C 40 aryl group, the same or different from each other, and R 1 and R 2 may be connected to each other to form part of a ring system.)
제 1항에 있어서, The method of claim 1, 상기 베타-플루오로알킬화 카보닐 화합물은 5-플루오로-4-(p-메틸페닐)-5,5-비스(페닐술포닐)펜탄-2-온, 5-플루오로-4-(p-메톡시페닐)-5,5-비스(페닐술포닐)펜탄-2-온, 5-플루오로-4-(p-플루오로페닐)-5,5-비스(페닐술포닐)펜탄-2-온, 5-플루오로-4-(1-나프틸)-5,5-비스(페닐술포닐)펜탄-2-온, 6-플루오로-5-페닐-6,6-비스(페닐술포닐)헥산-3-온, 6-플루오로-5-메틸-6,6-비스(페닐설폰)헥산-3-온, 3-[플루오로(비스페닐술포닐)메틸]싸이클로헥산온 및 3-[플루오로(비스페닐술포닐)메틸]싸이클로펜탄온으로 이루어진 그룹 중에서 선택된 것을 특징으로 하는 키랄 촉매를 이용한 베타-플루오로알킬화 카보닐 화합물의 제조방법.The beta-fluoroalkylated carbonyl compound is 5-fluoro-4- ( p -methylphenyl) -5,5-bis (phenylsulfonyl) pentan-2-one, 5-fluoro-4- ( p -meth Methoxyphenyl) -5,5-bis (phenylsulfonyl) pentan-2-one, 5-fluoro-4- ( p -fluorophenyl) -5,5-bis (phenylsulfonyl) pentan-2-one , 5-fluoro-4- (1-naphthyl) -5,5-bis (phenylsulfonyl) pentan-2-one, 6-fluoro-5-phenyl-6,6-bis (phenylsulfonyl) Hexane-3-one, 6-fluoro-5-methyl-6,6-bis (phenylsulfon) hexan-3-one, 3- [fluoro (bisphenylsulfonyl) methyl] cyclohexanone and 3- [ A method for producing a beta-fluoroalkylated carbonyl compound using a chiral catalyst, characterized in that it is selected from the group consisting of fluoro (bisphenylsulfonyl) methyl] cyclopentanone.
KR1020090096840A 2009-10-12 2009-10-12 Method for the preparation of chiral beta-fluoroalkylated carbonyl compounds using chiral catalyst KR101199178B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020090096840A KR101199178B1 (en) 2009-10-12 2009-10-12 Method for the preparation of chiral beta-fluoroalkylated carbonyl compounds using chiral catalyst

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020090096840A KR101199178B1 (en) 2009-10-12 2009-10-12 Method for the preparation of chiral beta-fluoroalkylated carbonyl compounds using chiral catalyst

Publications (2)

Publication Number Publication Date
KR20110039826A KR20110039826A (en) 2011-04-20
KR101199178B1 true KR101199178B1 (en) 2012-11-07

Family

ID=44046295

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020090096840A KR101199178B1 (en) 2009-10-12 2009-10-12 Method for the preparation of chiral beta-fluoroalkylated carbonyl compounds using chiral catalyst

Country Status (1)

Country Link
KR (1) KR101199178B1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101404616B1 (en) * 2012-06-07 2014-06-09 순천향대학교 산학협력단 Method for Preparation of γ-fluorinated ketone derivatives
KR101453414B1 (en) * 2013-01-08 2014-10-23 순천향대학교 산학협력단 Method for preparation of chiral tetrahydroquinolines

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Tetrahedron, Vol. 65, pp.4124~4129 (2009.03.27. 웹 공개).*

Also Published As

Publication number Publication date
KR20110039826A (en) 2011-04-20

Similar Documents

Publication Publication Date Title
Boobalan et al. Camphor-based Schiff base ligand SBAIB: an enantioselective catalyst for addition of phenylacetylene to aldehydes
KR20090118032A (en) Chiral iridium aqua complex and method for producing optically active hydroxy compound by using the same
JP2019089766A (en) Metalorganocatalysis for asymmetric transformations
Wang et al. Synthesis of chiral salan ligands with bulky substituents and their application in Cu-catalyzed asymmetric Henry reaction
KR101199178B1 (en) Method for the preparation of chiral beta-fluoroalkylated carbonyl compounds using chiral catalyst
EP1754739A1 (en) Deuterated polyimides and derivatives thereof
JP2010037332A (en) Chiral iridium aqua complex and method for producing optically active hydroxy compound using the same
Wang et al. Catalytic asymmetric aryl transfer: Highly enantioselective preparation of (R)-and (S)-diarylmethanols catalyzed by the same chiral ferrocenyl aziridino alcohol
JP2007063275A (en) Allyl-type alkylation by iron catalyst action
CN108101755B (en) Method for preparing chiral 4- (2-propargyl) phenol compound
Gou et al. Enantioselective alkynylation of aldehydes catalyzed by a camphor sulfonylated amino alcohols titanium (IV) catalyst system
JP5046213B2 (en) Process for producing optically active alcohol compounds
KR101344077B1 (en) Method for Preparation of Beta-indolyl Esters Using Chiral Palladium Complexes
CN110684043B (en) C-N axis chiral arylamine compound and preparation method thereof
CN111116450B (en) Axial chiral naphthylamine squaramide organic catalyst, and preparation method and application thereof
CN110372514B (en) Method for catalyzing asymmetric Michael addition reaction and catalyst thereof
CN114163313A (en) Method for selectively synthesizing EZ-stilbene by coupling aryl diazonium salt and cinnamic acid under catalysis of ruthenium
EP3609859B1 (en) Chiral metal complex compounds
CN113354582B (en) Method for catalytically synthesizing 1, 2-dihydroisoquinoline compounds by utilizing iridium complexes
US9340519B2 (en) Paracyclophane-based ligands, their preparation and use in catalysis
CN115286609B (en) Preparation method of 2-trifluoromethyl substituted dihydrobenzochromene
CN108101758B (en) Method for preparing chiral propargylated aliphatic six-membered carbocyclic ring compound
JP2018135292A (en) Method for producing optically active alcohol and asymmetric catalyst
JP2008545721A (en) Enantioselective reduction of ketones, .BETA.-ketoesters and ketimines over ruthenium catalysts with chiral diphosphonites as ligands
KR101347825B1 (en) Method for preparation of chiral α-chlorinated ester derivatives

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20161101

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20171102

Year of fee payment: 6

FPAY Annual fee payment

Payment date: 20181102

Year of fee payment: 7